Electrophysiological evidence of biphasic action of carnosine on long-term potentiation in urethane-anesthetized rats

Suer C., Dolu N., ARTIŞ A. S. , Sahin L., Aydogan S.

NEUROPEPTIDES, vol.45, no.1, pp.77-81, 2011 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Article
  • Volume: 45 Issue: 1
  • Publication Date: 2011
  • Doi Number: 10.1016/j.npep.2010.11.004
  • Title of Journal : NEUROPEPTIDES
  • Page Numbers: pp.77-81


Carnosine is a dipeptide synthesized by the carnosine synthetase from beta-alanine and L-histidine. The well-known effects of carnosine may be related with mechanisms producing long-term potentiation which is one of the electrophysiological signs of memory. In the present study we aimed to investigate the effect of four different doses of carnosine on long-term potentiation in urethane-anesthetized rat. A bipolar stimulating electrode was placed in the medial perforant path and a double-barrel glass micropipette was placed in the dentate gyrus as the recording electrode. Artificial cerebrospinal fluid (in the control group) or carnosine (0.1, 1, 10, and 100 mu g/mu L) was infused into the dentate gyrus. Our results showed that the I/O curve of the excitatory postsynaptic potential slope or population spike amplitude was not significantly shifted by carnosine. We found that population spike amplitude increased to 244% and 287% at the dose of 100 mu g/mu L in the post-tetanic and induction phases, respectively, but decreased to 163% and 186% at the dose of 0.1 mu g/mu L and to 145% and 162% at the dose of 1 mu g/mu L when compared with 203% and 232% of the control values. However, there were no significant differences for the slope of excitatory postsynaptic potential. Carnosine had no effect on the EPSP slope or PS amplitude recorded from the dentate gyrus in response to test stimuli when high-frequency stimulation was not delivered. In the present study, we speculated that the effects of carnosine in lower or higher doses could be explained by its effect on different processes, such as soluble guanylyl cyclase inhibition or the conversion of carnosine into histamine. (c) 2010 Elsevier Ltd. All rights reserved.